Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

Apixaban: an oral direct factor-xa inhibitor.

Jiménez D, Yusen RD, Ramacciotti E.

Adv Ther. 2012 Mar;29(3):187-201. doi: 10.1007/s12325-012-0003-2. Epub 2012 Feb 17. Review.

PMID:
22354465
[PubMed - indexed for MEDLINE]
2.

The role of apixaban for venous and arterial thromboembolic disease.

Prom R, Spinler SA.

Ann Pharmacother. 2011 Oct;45(10):1262-83. doi: 10.1345/aph.1Q119. Epub 2011 Sep 27. Review.

PMID:
21954450
[PubMed - indexed for MEDLINE]
3.

Apixaban: a novel oral inhibitor of factor Xa.

Nutescu E.

Am J Health Syst Pharm. 2012 Jul 1;69(13):1113-26. doi: 10.2146/ajhp110418. Review.

PMID:
22722590
[PubMed - indexed for MEDLINE]
4.

Apixaban: a new player in the anticoagulant class.

Agrawal R, Jain P, Dikshit SN.

Curr Drug Targets. 2012 Jun;13(6):863-75. Review.

PMID:
22250655
[PubMed - indexed for MEDLINE]
5.

Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.

Deeks ED.

Drugs. 2012 Jun 18;72(9):1271-91. doi: 10.2165/11209020-000000000-00000. Review.

PMID:
22686618
[PubMed - indexed for MEDLINE]
6.

Apixaban for the prevention of stroke in atrial fibrillation.

Littrell R, Flaker G.

Expert Rev Cardiovasc Ther. 2012 Feb;10(2):143-9. doi: 10.1586/erc.11.187. Review.

PMID:
22292869
[PubMed - indexed for MEDLINE]
7.

[Apixaban: pharmacology and action profile].

Gassanov N, Caglayan E, Er F.

Dtsch Med Wochenschr. 2012 Jan;137(4):138-41. doi: 10.1055/s-0031-1298816. Epub 2012 Jan 18. Review. German.

PMID:
22259168
[PubMed - indexed for MEDLINE]
8.

Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation.

Pujadas-Mestres L, Escolar G, Arellano-Rodrigo E, Galán AM.

Drugs Today (Barc). 2013 Jul;49(7):425-36. doi: 10.1358/dot.2013.49.7.1980498. Review.

PMID:
23914351
[PubMed - indexed for MEDLINE]
9.

The safety and efficacy of apixaban : where do we stand in 2013?

de Souza Brito F, Lopes RD, Alexander JH.

Expert Opin Drug Saf. 2013 Jul;12(4):559-67. doi: 10.1517/14740338.2013.799663. Epub 2013 May 10. Review.

PMID:
23662974
[PubMed - indexed for MEDLINE]
10.

Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.

Lassen MR.

Drugs Today (Barc). 2012 Apr;48(4):249-58. doi: 10.1358/dot.2012.48.4.1738052. Review.

PMID:
22536567
[PubMed - indexed for MEDLINE]
11.

Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Keating GM.

Drugs. 2013 Jun;73(8):825-43. doi: 10.1007/s40265-013-0063-x. Review.

PMID:
23677804
[PubMed - indexed for MEDLINE]
12.

Apixaban in acute coronary syndromes.

Karthikeyan G, Eikelboom JW.

Cardiovasc Ther. 2011 Oct;29(5):285-90. doi: 10.1111/j.1755-5922.2010.00195.x. Epub 2010 Jun 11. Review.

PMID:
20553278
[PubMed - indexed for MEDLINE]
13.

Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.

Martin MT, Nutescu EA.

Curr Med Res Opin. 2011 Nov;27(11):2123-31. doi: 10.1185/03007995.2011.619178. Epub 2011 Sep 23. Review.

PMID:
21942466
[PubMed - indexed for MEDLINE]
14.

Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes.

Romualdi E, Ageno W.

Expert Opin Investig Drugs. 2011 Apr;20(4):495-505. doi: 10.1517/13543784.2011.562190. Epub 2011 Mar 9. Review.

PMID:
21385107
[PubMed - indexed for MEDLINE]
15.

[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].

Dumont B, Faille D, Ajzenberg N.

Med Sci (Paris). 2011 May;27(5):493-500. doi: 10.1051/medsci/2011275014. Epub 2011 May 25. Review. French.

PMID:
21609670
[PubMed - indexed for MEDLINE]
Free Article
16.

Apixaban and atrial fibrillation: no clear advantage.

[No authors listed]

Prescrire Int. 2014 Feb;23(146):33-6. Review.

PMID:
24669381
[PubMed - indexed for MEDLINE]
17.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
[PubMed - indexed for MEDLINE]
18.

Apixaban. After hip or knee replacement: LMWH remains the standard treatment.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):201-2, 204. Review.

PMID:
23016247
[PubMed - indexed for MEDLINE]
19.

Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.

Khemasuwan D, Suramaethakul N.

Clin Appl Thromb Hemost. 2012 Sep;18(5):476-86. doi: 10.1177/1076029612438957. Epub 2012 Mar 2. Review.

PMID:
22387584
[PubMed - indexed for MEDLINE]
20.

Apixaban, an oral, direct inhibitor of activated Factor Xa.

Shantsila E, Lip GY.

Curr Opin Investig Drugs. 2008 Sep;9(9):1020-33. Review.

PMID:
18729009
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk